Snider Financial Group Has $3.49 Million Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Snider Financial Group raised its position in iShares Biotechnology ETF (NASDAQ:IBB) by 19.8% during the third quarter, according to its most recent 13F filing with the SEC. The fund owned 24,000 shares of the financial services provider’s stock after buying an additional 3,970 shares during the period. iShares Biotechnology ETF comprises approximately 1.3% of Snider Financial Group’s holdings, making the stock its 28th largest holding. Snider Financial Group’s holdings in iShares Biotechnology ETF were worth $3,494,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Williams Financial LLC acquired a new position in shares of iShares Biotechnology ETF during the second quarter valued at $867,000. PVG Asset Management Corp bought a new stake in iShares Biotechnology ETF during the 2nd quarter worth about $415,000. Avantax Advisory Services Inc. lifted its position in iShares Biotechnology ETF by 38.4% during the 1st quarter. Avantax Advisory Services Inc. now owns 5,287 shares of the financial services provider’s stock valued at $726,000 after purchasing an additional 1,466 shares during the period. Concourse Financial Group Securities Inc. boosted its stake in shares of iShares Biotechnology ETF by 22.4% in the 2nd quarter. Concourse Financial Group Securities Inc. now owns 656 shares of the financial services provider’s stock valued at $90,000 after purchasing an additional 120 shares during the last quarter. Finally, Raymond James & Associates boosted its stake in shares of iShares Biotechnology ETF by 4.4% in the 2nd quarter. Raymond James & Associates now owns 189,766 shares of the financial services provider’s stock valued at $26,047,000 after purchasing an additional 7,931 shares during the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

IBB opened at $144.45 on Thursday. The firm has a 50 day simple moving average of $144.78 and a 200 day simple moving average of $141.57. iShares Biotechnology ETF has a fifty-two week low of $116.70 and a fifty-two week high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The firm also recently announced a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were given a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.